D. Mowles

发表

Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.

Stephen A Baldwin, C. Cass, S. Baldwin, 2009, American journal of physiology. Renal physiology.

Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)*

R. Hyde, S. Yao, C. Cass, 2001, The Journal of Biological Chemistry.

A Comparison of the Transportability, and Its Role in Cytotoxicity, of Clofarabine, Cladribine, and Fludarabine by Recombinant Human Nucleoside Transporters Produced in Three Model Expression Systems

S. Yao, C. Cass, A. Ng, 2006, Molecular Pharmacology.

Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.

C. Cass, M. Sawyer, R. Berendt, 2008, Biochemical pharmacology.

Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.

C. Cass, J. Young, H. Gourdeau, 2001, Cancer research.

Differential Transport of Cytosine-Containing Nucleosides by Recombinant Human Concentrative Nucleoside Transporter Protein hCNT1

J. Mackey, C. Cass, K. Graham, 2000, Nucleosides, nucleotides & nucleic acids.

Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.

C. Cass, J. Young, X. Fang, 1996, The Biochemical journal.

Role of Human Nucleoside Transporters in the Cellular Uptake of Two Inhibitors of IMP Dehydrogenase, Tiazofurin and Benzamide Riboside

C. Cass, A. Ng, V. Damaraju, 2005, Molecular Pharmacology.

Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.

C. Cass, V. Damaraju, D. Mowles, 2011, Biochemical pharmacology.

Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabine.

C. Cass, Yunshan Peng, V. Damaraju, 2010, Journal of medicinal chemistry.

The Role of Human Nucleoside Transporters in Cellular Uptake of 4′-Thio-β-d-arabinofuranosylcytosine and β-d-Arabinosylcytosine

C. Cass, B. Tomkinson, V. Damaraju, 2006, Molecular Pharmacology.

The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.

C. Cass, B. Tomkinson, V. Damaraju, 2006, Molecular pharmacology.

Influence of Sugar Ring Conformation on the Transportability of Nucleosides by Human Nucleoside Transporters

S. Yao, C. Cass, V. Marquez, 2011, Chembiochem : a European journal of chemical biology.

Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: role of thymidine kinase 2.

C. Cass, M. Sawyer, S. Damaraju, 2010, Biochemical pharmacology.

Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.

C. R. Crawford, R S Mani, J. Mackey, 1998, Cancer research.

Cellular Influx, Efflux, and Anabolism of 3-Carboranyl Thymidine Analogs: Potential Boron Delivery Agents for Neutron Capture Therapy

C. Cass, H. Agarwal, M. Sawyer, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.

C. Cass, P. Gros, Yunshan Peng, 2008, Cancer research.

Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?

C. Cass, M. Sawyer, V. Damaraju, 2014, Molecular Cancer Therapeutics.

Role of Human Nucleoside Transporters in the Uptake and Cytotoxicity of Azacitidine and Decitabine

S. Yao, C. Cass, A. Ng, 2012, Nucleosides, nucleotides & nucleic acids.

Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers.

C. Cass, M. Sawyer, V. Damaraju, 2013, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity

Carol E. Cass, Michelle Kuzma, Anderson J. Ryan, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical Erlotinib , Ge fi tinib , and Vandetanib Inhibit HumanNucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity

C. Cass, M. Sawyer, A. Ryan, 2013 .

Nucleoside transporter gene expression in wild-type and mENT1 knockout mice.

S. Yao, C. Cass, A. Ng, 2011, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Inhibition by arabinosylcytosine of DNA synthesis in bone marrows of relapsed AML patients.

A. Belch, D. Mowles, L. Brox, 1979, European Journal of Cancer.

Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.

C. Cass, S. Baldwin, M. Sawyer, 2009, American journal of physiology. Renal physiology.

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity

C. Cass, M. Sawyer, A. Ryan, 2013, Clinical Cancer Research.